Health-related quality of life in patients on hemodialysis and peritoneal dialysis

Abstract EN

Chronic kidney disease (CKD) is a worldwide public health problem, and its treatment imposes a considerable burden on patients and their families.

Limitations in everyday activity may worsen the situation and affect the health-related quality of life (HRQOL) of patients with CKD.

There are no studies on the HRQOL of dialysis patients in South Africa.

We assessed the HRQOL of patients undergoing hemodialysis (HD) and continuous ambulatory peritoneal dialysis (PD) attending the Groote Schuur Hospital renal unit by using the Kidney Disease Quality of Life-Short Form version 1.3 questionnaire.

Baseline demographic and clinical details of the participants were recorded.

Analysis was performed (unpaired t test and univariate analysis) to compare the HRQOL between HD and PD patients and to identify factors influencing HRQOL.

The HRQOL was low but not significantly different between HD and PD patients.

In PD patients, the use of erythropoiesis-stimulating agents (ESA) significantly contributed to the emotional well-being (r 2 = 0.267 ; P = 0.01) and alleviation of pain (r 2 = 0.073 ; P = 0.049); in HD patients also, ESA use was associated with emotional well-being (r 2 = 0.258 ; P < 0.0001) as well as improvement in energy / fatigue (r 2 = 0.390 ; P < 0.0001).

Systolic and diastolic blood pressures significantly influenced cognitive function in PD patients (P < 0.05).

Parathyroid hormone level significantly influenced the physical functioning and energy / fatigue domains in HD patients (P < 0.0001).

Serum ferritin (r 2 = 0.441 ; P = 0.002) and level of hemoglobin concentration (r 2 = 0.180; P = 0.006) were significantly associated with the domain role emotional in PD and HD patients, respectively.

Although HRQOL is low in dialysis patients in Cape Town, the factors that have been identified to be associated with these scores (such as anemia and hyperparathyroidism) if aggressively managed and corrected may assist in improving patients' HRQOL.